We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.91B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+24.21%
3 Year Est. Return
+168.27%
5 Year Est. Return
+91.75%
10 Year Est. Return
+1,020.11%
AUM
$3.33B
AUM Growth
-$299M
Cap. Flow
-$343M
Cap. Flow %
-10.3%
Top 10 Hldgs %
95.6%
Holding
16
New
1
Increased
3
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$96.9M
2
ALKT icon
Alkami Technology
ALKT
+$59.9M
3
PHVS icon
Pharvaris
PHVS
+$11.1M
4
BULL
Webull Corp
BULL
+$725K

Top Sells

Rank Stock Value
1
ALHC icon
Alignment Healthcare
ALHC
+$292M
2
DLO icon
dLocal
DLO
+$219M
3
ADAG
Adagene
ADAG
+$89.2K

Sector Composition

Rank Sector Weight
1 Technology 44.52%
2 Healthcare 39.4%
3 Financials 14.4%
4 Consumer Staples 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLO icon
1
dLocal
DLO
$4.42B
$666M 20%
46,656,695
-17,250,000
-27% -$219M
XP icon
2
XP
XP
$8.96B
$479M 14.4%
25,517,733
– –
ALHC icon
3
Alignment Healthcare
ALHC
$2.83B
$424M 12.72%
24,287,227
-19,706,096
-45% -$292M
CHYM
4
Chime Financial
CHYM
$12.6B
$387M 11.63%
19,208,760
– –
ALKT icon
5
Alkami Technology
ALKT
$2.16B
$298M 8.94%
11,991,480
+2,346,162
+24% +$59.9M
AKRO
6
DELISTED
Akero Therapeutics
AKRO
$272M 8.17%
5,733,989
– –
CNTA
7
DELISTED
Centessa Pharmaceuticals
CNTA
$235M 7.05%
9,681,818
– –
PHVS icon
8
Pharvaris
PHVS
$2.48B
$200M 6.02%
8,031,252
+500,000
+7% +$11.1M
RVMD icon
9
Revolution Medicines
RVMD
$44.6B
$116M 3.47%
+2,474,428
New +$96.9M
BULL
10
Webull Corp
BULL
$4.96B
$106M 3.2%
7,198,867
+50,816
+0.7% +$725K
RPRX icon
11
Royalty Pharma
RPRX
$27.1B
$52.9M 1.59%
1,500,000
– –
EWCZ
12
DELISTED
European Wax Center
EWCZ
$52.3M 1.57%
13,110,492
– –
RSKD icon
13
Riskified
RSKD
$833M
$24.9M 0.75%
5,324,998
– –
ADAG
14
Adagene
ADAG
$247M
$7.53M 0.23%
3,782,339
-43,613
-1% -$89.2K
ALMS
15
Alumis Inc
ALMS
$2.9B
$5.18M 0.16%
1,297,530
– –
GROV icon
16
Grove Collaborative
GROV
$42.7M
$3.71M 0.11%
2,474,859
– –

Similar funds

LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $2.91B AUM 27.09% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
7WCP
71 West Capital Partners Boston, Massachusetts $2.89B AUM
JC
JB Capital Wethersfield, Connecticut $2.89B AUM 29.25% 1-Year Est. Return

General Atlantic's Q3 2025 Portfolio in Review

As of Q3 2025, General Atlantic held 16 positions worth $3.33B, down 8.2% from $3.63B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

General Atlantic withdrew a net $343M in Q3 2025, reducing 3 holdings. Its largest reduction was Alignment Healthcare, cutting an estimated $292M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic opened a new position in Revolution Medicines worth $116M.

  • General Atlantic's largest Q3 2025 buy was Revolution Medicines: 2,474,428 shares worth $116M.
  • General Atlantic added most to Alkami Technology in Q3 2025, an estimated $59.9M increase.
  • General Atlantic's biggest Q3 2025 reduction was Alignment Healthcare, cutting an estimated $292M.
  • General Atlantic's ten largest holdings make up 96% of its $3.33B portfolio in Q3 2025.
  • General Atlantic opened 1 new position and closed 0 in Q3 2025.
  • General Atlantic's portfolio value fell 8.2% quarter-over-quarter to $3.33B.

Based on General Atlantic's 13F filing for Q3 2025, filed 13 Nov 2025.